Cann Group Ltd (CAN) - Cash Flow Conversion Efficiency

Latest as of June 2025: 1.840x

Based on the latest financial reports, Cann Group Ltd (CAN) has a cash flow conversion efficiency ratio of 1.840x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.11 Million ≈ $-3.61 Million USD) by net assets (AU$-2.77 Million ≈ $-1.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cann Group Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Cann Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Cann Group Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Cann Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cann Group Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
WE WIN LIMITED NSE:WEWIN	0.048x
ABAS Protect AB ST:ABAS	N/A
BioLight Life Sciences Ltd TA:BOLT	-0.137x
JE Cleantech Holdings Ltd NASDAQ:JCSE	0.001x
Eminence Minerals Limited AU:EMA	-0.107x
Boqii Holding Limited NYSE:BQ	0.002x
Wirtek A/S CO:WIRTEK	0.175x
UNIDOC HEALTH CORP. F:L7T	N/A

Annual Cash Flow Conversion Efficiency for Cann Group Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Cann Group Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see CAN company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-2.77 Million ≈ $-1.96 Million	AU$-9.64 Million ≈ $-6.82 Million	3.475x	+418.57%
2024-06-30	AU$13.92 Million ≈ $9.85 Million	AU$-15.19 Million ≈ $-10.74 Million	-1.091x	-183.08%
2023-06-30	AU$59.26 Million ≈ $41.93 Million	AU$-22.84 Million ≈ $-16.16 Million	-0.385x	-60.11%
2022-06-30	AU$84.90 Million ≈ $60.07 Million	AU$-20.43 Million ≈ $-14.46 Million	-0.241x	-6.15%
2021-06-30	AU$91.87 Million ≈ $65.01 Million	AU$-20.83 Million ≈ $-14.74 Million	-0.227x	+21.40%
2020-06-30	AU$61.07 Million ≈ $43.21 Million	AU$-17.62 Million ≈ $-12.47 Million	-0.288x	-200.42%
2019-06-30	AU$77.30 Million ≈ $54.69 Million	AU$-7.42 Million ≈ $-5.25 Million	-0.096x	-119.63%
2018-06-30	AU$85.87 Million ≈ $60.76 Million	AU$-3.75 Million ≈ $-2.66 Million	-0.044x	+72.12%
2017-06-30	AU$14.66 Million ≈ $10.37 Million	AU$-2.30 Million ≈ $-1.63 Million	-0.157x	+78.75%
2016-06-30	AU$1.69 Million ≈ $1.20 Million	AU$-1.25 Million ≈ $-882.14K	-0.738x	+25.57%
2015-06-30	AU$648.33K ≈ $458.73K	AU$-642.74K ≈ $-454.78K	-0.991x	--

About Cann Group Ltd

AU:CAN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$5.62 Million

AU$7.94 Million AUD

Market Cap Rank

#28124 Global

#1532 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$3.98